Antony Rosen Selected Research

RNA Polymerase III

1/2019	Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
9/2017	Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease.
1/2017	Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.
4/2015	Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.
11/2011	Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.
9/2010	Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antony Rosen Research Topics

Disease

23	Neoplasms (Cancer) 07/2023 - 10/2003
14	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 09/2003
13	Myositis (Idiopathic Inflammatory Myopathies) 01/2023 - 09/2002
12	Rheumatoid Arthritis 01/2021 - 07/2008
10	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 07/2002
10	Rheumatic Diseases (Rheumatism) 01/2023 - 07/2008
10	Dermatomyositis (Dermatopolymyositis) 01/2023 - 09/2002
9	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 08/2007
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 09/2003
4	Pulmonary Hypertension 01/2021 - 02/2003
3	Blister (Bulla) 09/2022 - 09/2003
3	COVID-19 05/2022 - 10/2020
3	Melanoma (Melanoma, Malignant) 05/2022 - 07/2011
3	Disease Progression 01/2021 - 11/2003
3	Vascular Diseases (Vascular Disease) 10/2016 - 08/2009
3	Inflammation (Inflammations) 08/2013 - 11/2003
2	Inclusion Body Myositis 01/2023 - 06/2016
2	Muscular Diseases (Myopathy) 01/2023 - 03/2011
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2017
2	Arthritis (Polyarthritis) 12/2016 - 07/2011
2	Polymyositis 06/2016 - 09/2002
2	Infections 01/2016 - 09/2003
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 10/2003
2	Hepatitis C 09/2013 - 09/2012
2	Thyroiditis 09/2013 - 09/2012
1	Calcinosis 11/2023
1	Constipation 08/2023
1	Muscle Weakness 05/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Obesity 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Fever (Fevers) 01/2021
1	Hypoalbuminemia 01/2021
1	Proteinuria 07/2019
1	Stroke (Strokes) 07/2019
1	Lupus Nephritis 07/2019
1	Retinoblastoma (Glioblastoma, Retinal) 07/2019
1	Anemia 07/2019

Drug/Important Bio-Agent (IBA)

47	AutoantibodiesIBA 11/2023 - 07/2002
29	AutoantigensIBA 01/2022 - 07/2002
28	AntibodiesIBA 11/2023 - 02/2003
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2005
9	Granzymes (Granzyme)IBA 09/2022 - 07/2002
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2008
7	AntigensIBA 01/2016 - 02/2005
6	EnzymesIBA 01/2023 - 03/2011
6	RNA Polymerase IIIIBA 01/2019 - 09/2010
5	Protein-Arginine Deiminase Type 4IBA 01/2018 - 07/2008
4	InterferonsIBA 01/2022 - 09/2012
4	Protein-Arginine DeiminasesIBA 01/2019 - 01/2012
4	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 09/2010
3	ImmunosorbentsIBA 01/2023 - 03/2011
3	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 03/2011
3	RNA (Ribonucleic Acid)IBA 09/2022 - 11/2016
3	Immunoglobulin M (IgM)IBA 05/2022 - 10/2020
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2021 - 09/2010
3	RNA Polymerase I (Polymerase I, RNA)IBA 02/2021 - 09/2010
3	NucleophosminIBA 01/2014 - 10/2003
2	Coenzyme A (CoA)IBA 01/2023 - 01/2023
2	IFIH1 Interferon-Induced HelicaseIBA 01/2023 - 07/2012
2	Peptide Hydrolases (Proteases)FDA Link 09/2022 - 10/2003
2	AngiotensinsIBA 05/2022 - 10/2020
2	Antinuclear AntibodiesIBA 01/2021 - 09/2015
2	ChromatinIBA 07/2019 - 12/2009
2	anti-RNA-polymerase III autoantibodyIBA 01/2018 - 11/2011
2	EpitopesIBA 01/2017 - 10/2003
2	trioctyl phosphine oxide (TOPO)IBA 01/2017 - 01/2016
2	arginine deiminaseIBA 10/2016 - 01/2014
2	anti-scl-70 autoantibodiesIBA 01/2016 - 04/2015
2	CalciumIBA 01/2014 - 05/2013
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 08/2007 - 11/2003
2	Serine Proteases (Serine Protease)IBA 01/2004 - 09/2003
1	gephyrinIBA 08/2023
1	UbiquitinIBA 01/2023
1	nuclear matrix protein 2IBA 01/2023
1	sperm releasing substanceIBA 01/2023
1	Mi-2 antibodiesIBA 01/2023
1	ElementsIBA 09/2022
1	Retroelements (Retrotransposon)IBA 09/2022
1	Methylprednisolone FDA LinkGeneric 05/2022
1	transcriptional intermediary factor 1IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021
1	TroponinIBA 01/2021
1	Antiphospholipid AntibodiesIBA 07/2019
1	Retinoblastoma ProteinIBA 07/2019
1	HeterochromatinIBA 07/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2019
1	Nucleosomes (Nucleosome)IBA 07/2019

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2012
1	Precision Medicine 12/2021
1	Home Nursing (Nursing, Home) 01/2021